Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

REGN

Regeneron Pharmaceuticals (REGN)

Regeneron Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:REGN
DateTimeSourceHeadlineSymbolCompany
10/12/201909:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:REGNRegeneron Pharmaceuticals Inc
09/12/201901:00PR Newswire (US)First Clinical Data for REGN5458 (BCMAxCD3) Show Positive Preliminary Results in Multiple MyelomaNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/12/201901:40Dow Jones NewsRegeneron Reports Positive Phase 2 Data for Pozelimab in PNHNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/12/201923:00PR Newswire (US)Regeneron Announces Positive Topline Phase 2 Data with Anti-C5 Antibody Pozelimab in Patients with a Rare Blood DisorderNASDAQ:REGNRegeneron Pharmaceuticals Inc
03/12/201908:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
28/11/201909:29Dow Jones NewsEarly Drug Treatment Sharply Reduces Deaths From EbolaNASDAQ:REGNRegeneron Pharmaceuticals Inc
28/11/201909:00PR Newswire (US)New England Journal of Medicine Publishes Results of Ebola Clinical Trial Confirming Superiority of Regeneron's REGN-EB3 to Z...NASDAQ:REGNRegeneron Pharmaceuticals Inc
27/11/201908:31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
27/11/201908:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
23/11/201908:08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
22/11/201923:00PR Newswire (US)Regeneron's Yancopoulos Receives Columbia College's Alexander Hamilton AwardNASDAQ:REGNRegeneron Pharmaceuticals Inc
14/11/201908:12Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
13/11/201908:06Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
12/11/201923:30PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
09/11/201909:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:REGNRegeneron Pharmaceuticals Inc
07/11/201901:00PR Newswire (US)Regeneron to Report Results from CD20xCD3 and BCMAxCD3 Bispecifics and C5 Antibody Programs at ASH Annual meetingNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201923:00PR Newswire (US)Regeneron and Vyriad Announce Strategic Agreement for Discovery and Development of New Oncolytic Virus Treatments for CancerNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201905:29Dow Jones NewsRegeneron Pharmaceuticals Up Over 9%, on Pace for Largest Percent Increase Since November 2016 -- Data TalkNASDAQ:REGNRegeneron Pharmaceuticals Inc
06/11/201900:25Dow Jones NewsRegeneron Pharmaceuticals Board Approves $1 Billion BuybackNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/11/201923:49Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/11/201923:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:REGNRegeneron Pharmaceuticals Inc
05/11/201923:14Dow Jones NewsRegeneron Pharmaceuticals Reports Higher 3Q ProfitNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/11/201922:40PR Newswire (US)Regeneron Provides Updates on Phase 3 Libtayo® (cemiplimab) Development Program in Advanced Non-small Cell Lung CancerNASDAQ:REGNRegeneron Pharmaceuticals Inc
05/11/201922:30PR Newswire (US)Regeneron Reports Third Quarter 2019 Financial and Operating ResultsNASDAQ:REGNRegeneron Pharmaceuticals Inc
30/10/201900:12Dow Jones NewsSanofi, Regeneron Gets EU OK for Expanded Dupixent UseNASDAQ:REGNRegeneron Pharmaceuticals Inc
29/10/201923:15PR Newswire (US)Dupixent® (dupilumab) Now Approved in European Union for Severe Chronic Rhinosinusitis with Nasal PolyposisNASDAQ:REGNRegeneron Pharmaceuticals Inc
25/10/201922:05PR Newswire (US)Regeneron Ranked #2 in Science Magazine's Top Biopharma Companies to Work ForNASDAQ:REGNRegeneron Pharmaceuticals Inc
25/10/201922:00PR Newswire (US)Regeneron Colleagues Support 150 Community Organizations During Third Annual Day for Doing GoodNASDAQ:REGNRegeneron Pharmaceuticals Inc
18/10/201923:30PR Newswire (US)Regeneron Announces Upcoming Investor Conference PresentationsNASDAQ:REGNRegeneron Pharmaceuticals Inc
11/10/201900:30PR Newswire (US)Regeneron to Report Third Quarter 2019 Financial and Operating Results and Host Conference Call and Webcast on November 5, 20...NASDAQ:REGNRegeneron Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:REGN